Hints and tips:
Related Special Reports
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
Company would have been better off following Roche’s route to market for anti-obesity treatment
...Nike, with shares down 20 per cent in the past 12 months, is still taking strides to get its innovation mojo back....
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...Unhedged, on the other hand, is taking it in stride, as you will see below. Email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...Some pharma companies disputed the annual cost figures published by the health department....
...A shrinking domestic market is forcing Japan Inc to look for growth overseas. Ultra-low interest rates back home have further whetted the appetite for deals....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Big Pharma has always bought out small drug developers to restock its pipelines. Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
...Nike is finally starting to regain its stride. The sportswear giant has had a tough run in recent quarters....
US regulator sues to block takeover of biotech group Horizon Therapeutics
...As the star strides pensively through airports and urban nightscapes, your mind may turn to the true mystery of The Killer....
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
Astellas CEO says company will diversify supply chains in first comments since employee’s detention
...Once it gets into its stride, however, Death in the Blood becomes a gripping narrative, strengthened by Wheeler’s longstanding connection to the story....
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
...Late on Friday, a New Jersey bankruptcy court ruled that the big pharma company could not pursue a bankruptcy deal with tens of thousands of consumers who claim its talc powder caused serious illness....
International Edition